Title : Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.

Pub. Date : 2007 Mar

PMID : 17229571






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Calcitriol inhibits the prostaglandin (PG) pathway by three actions: (i) the inhibition of the expression of cyclooxygenase-2 (COX-2), the enzyme that synthesizes PGs, (ii) the induction of the expression of 15-prostaglandin dehydrogenase (15-PGDH), the enzyme that inactivates PGs and (iii) decreasing the expression of EP and FP PG receptors that are essential for PG signaling. Phosphatidylglycerols prostaglandin-endoperoxide synthase 2 Homo sapiens
2 Calcitriol inhibits the prostaglandin (PG) pathway by three actions: (i) the inhibition of the expression of cyclooxygenase-2 (COX-2), the enzyme that synthesizes PGs, (ii) the induction of the expression of 15-prostaglandin dehydrogenase (15-PGDH), the enzyme that inactivates PGs and (iii) decreasing the expression of EP and FP PG receptors that are essential for PG signaling. Phosphatidylglycerols prostaglandin-endoperoxide synthase 2 Homo sapiens
3 Calcitriol inhibits the prostaglandin (PG) pathway by three actions: (i) the inhibition of the expression of cyclooxygenase-2 (COX-2), the enzyme that synthesizes PGs, (ii) the induction of the expression of 15-prostaglandin dehydrogenase (15-PGDH), the enzyme that inactivates PGs and (iii) decreasing the expression of EP and FP PG receptors that are essential for PG signaling. Phosphatidylglycerols prostaglandin-endoperoxide synthase 2 Homo sapiens